Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	92
Overall Study	STARTED	Paroxetine 20 mg	85
Overall Study	STARTED	Vortioxetine 10 mg	91
Overall Study	STARTED	Vortioxetine 20 mg	93
Overall Study	Treated	Placebo	91
Overall Study	Treated	Paroxetine 20 mg	84
Overall Study	Treated	Vortioxetine 10 mg	91
Overall Study	Treated	Vortioxetine 20 mg	91
Overall Study	COMPLETED	Placebo	76
Overall Study	COMPLETED	Paroxetine 20 mg	67
Overall Study	COMPLETED	Vortioxetine 10 mg	68
Overall Study	COMPLETED	Vortioxetine 20 mg	79
Overall Study	NOT COMPLETED	Placebo	16
Overall Study	NOT COMPLETED	Paroxetine 20 mg	18
Overall Study	NOT COMPLETED	Vortioxetine 10 mg	23
Overall Study	NOT COMPLETED	Vortioxetine 20 mg	14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02932904/flow